Journal of Child Neurology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naidu, S.
Right arrow Articles by Johnston, M. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naidu, S.
Right arrow Articles by Johnston, M. V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Child Neurology, Vol. 18, No. 10, 662-668 (2003)
DOI: 10.1177/08830738030180100801

Clinical Variability in Rett Syndrome

SakkuBai Naidu, MD

Department of Neurogenetics, Kennedy Krieger Institute, naidu{at}kennedykrieger.org., Departments of Neurology and Pediatrics, The Johns Hopkins School of Medicine

Genila Bibat, MD

Department of Neurogenetics, Kennedy Krieger Institute, Department of Pediatrics, The Johns Hopkins School of Medicine

Lisa Kratz, PhD

Division of Metabolism, Kennedy Krieger Institute

Richard I. Kelley, MD, PhD

Division of Metabolism, Kennedy Krieger Institute, Department of Pediatrics, The Johns Hopkins School of Medicine

Jonathan Pevsner, PhD

Department of Neurology, Kennedy Krieger Institute, Department of Neuroscience, The Johns Hopkins School of Medicine

Eric Hoffman, PhD

Center for Genetic Medicine Children's National Medical Center, Washington, DC

Carmen Cuffari, MD

Department of Pediatrics, The Johns Hopkins School of Medicine

Charles Rohde, PhD

Department of Biostatistics The Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, MD

Mary E. Blue, PhD

Department of Neuroscience, Kennedy Krieger Institute, Departments of Neurology and Neuroscience The Johns Hopkins School of Medicine

Michael V. Johnston, MD

Division of Neurology and Developmental Medicine Kennedy Krieger Institute, Baltimore,, Departments of Neurology and Pediatrics, The Johns Hopkins School of Medicine

The clinical variability of Rett syndrome, associated with mutations in the MECP2 gene, varies from classically symptomatic female patients to asymptomatic female patients, and male patients who have none of the diagnostic features considered pathognomonic of this disease. Multiple factors contribute to this variability. In our studies, mutations closer to the amino-terminus, prior to amino acid 255, led to severe clinical manifestations, such as inability to walk, severe dysphagia, and urinary organic acid abnormalities, compared with mutations toward the carboxyl-terminus. However, we found no correlation between severity and mutation type (missense versus nonsense). Despite the importance of mutation location to clinical severity, the widely varying severity within the same mutation suggests that in females, X-chromosome inactivation or other epigenetic phenomena also have roles in determining severity. We propose that stages 1 and 2 of the disease are a consequence of failed, time-linked, postnatal expression of MeCP2 in cerebellar neurons. This, in association with glutamate N-methyl-D-aspartate receptor—mediated neuroexcitotoxic injury to the differentiating neurons, results in the transient age-specific autistic-like behavior, motor, and cognitive dysfunction associated with these stages. (J Child Neurol 2003; 18:662-668).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
J.C. Carter, D.C. Lanham, D. Pham, G. Bibat, S. Naidu, and W.E. Kaufmann
Selective Cerebral Volume Reduction in Rett Syndrome: A Multiple-Approach MR Imaging Study
AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 436 - 441.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
Y Petel-Galil, B Ben-Zeev, I Greenbaum, M Vecsler, B Goldman, H Lohi, B A Minassian, and E Gak
Comprehensive diagnosis of Rett's syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patients
J. Med. Genet., December 1, 2006; 43(12): e56 - e56.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
J. Christodoulou and L. S. Weaving
MECP2 and Beyond: Phenotype--Genotype Correlations in Rett Syndrome
J Child Neurol, October 1, 2003; 18(10): 669 - 674.
[Abstract] [PDF]